| 标题 |
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Gynecologic Oncology 作者:D. Richardson; K. Moore; I. Vergote; Lucy Gilbert; Lainie P. Martin; et al 出版日期:2024-03-05 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)